These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 528125)

  • 1. Effects of a combined behavioral and pharmacological program on weight loss.
    Brightwell DR; Naylor CS
    Int J Obes; 1979; 3(2):141-8. PubMed ID: 528125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase.
    Weintraub M; Sundaresan PR; Schuster B; Averbuch M; Stein EC; Cox C; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):608-14. PubMed ID: 1587075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
    Weintraub M; Sundaresan PR; Madan M; Schuster B; Balder A; Lasagna L; Cox C
    Clin Pharmacol Ther; 1992 May; 51(5):586-94. PubMed ID: 1587072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on weight reduction and safety of short-term phentermine administration in Korean obese people.
    Kim KK; Cho HJ; Kang HC; Youn BB; Lee KR
    Yonsei Med J; 2006 Oct; 47(5):614-25. PubMed ID: 17066505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phentermine levels, weight loss and side-effects.
    Douglas A; Douglas JG; Robertson CE; Munro JF
    Int J Obes; 1983; 7(6):591-5. PubMed ID: 6654575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological treatment of obesity with phentermine resin as an adjunct.
    Roberts CR
    Am J Psychiatry; 1978 Aug; 135(8):936-9. PubMed ID: 665837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
    Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
    Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.
    Weintraub M; Sundaresan PR; Schuster B; Moscucci M; Stein EC
    Clin Pharmacol Ther; 1992 May; 51(5):602-7. PubMed ID: 1587074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of behavioral techniques reinforced with an anorectic drug in a double-blind weight loss study.
    Abramson R; Garg M; Cioffari A; Rotman PA
    J Clin Psychiatry; 1980 Jul; 41(7):234-7. PubMed ID: 6993445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings.
    Moldovan CP; Weldon AJ; Daher NS; Schneider LE; Bellinger DL; Berk LS; Hermé AC; Aréchiga AL; Davis WL; Peters WR
    Obesity (Silver Spring); 2016 Nov; 24(11):2344-2350. PubMed ID: 27664021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
    Kang JG; Park CY; Kang JH; Park YW; Park SW
    Diabetes Obes Metab; 2010 Oct; 12(10):876-82. PubMed ID: 20920040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phentermine/topiramate for the treatment of obesity.
    Smith SM; Meyer M; Trinkley KE
    Ann Pharmacother; 2013 Mar; 47(3):340-9. PubMed ID: 23482732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication.
    Weintraub M; Sundaresan PR; Schuster B; Averbuch M; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):615-8. PubMed ID: 1587076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
    Langlois KJ; Forbes JA; Bell GW; Grant GF
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2).
    Davidson MH; Tonstad S; Oparil S; Schwiers M; Day WW; Bowden CH
    Am J Cardiol; 2013 Apr; 111(8):1131-8. PubMed ID: 23375187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
    Hendricks EJ; Greenway FL; Westman EC; Gupta AK
    Obesity (Silver Spring); 2011 Dec; 19(12):2351-60. PubMed ID: 21527891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.